Clinical Trials Browser

Active not recruiting × Interventional × LB100 × Clear all

NCT04560972 2025-11-10

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

Phase 1 Active not recruiting

Extensive Stage Lung Small Cell Carcinoma